Clinical Trial Update: Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating two experimental analgesics, ADL5859 and ADL5747, for relief of pain due to osteoarthritis of the knee, with safety data collec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• ADL5747
• ADL5859

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2015-05-07